MED Q1 2026 Earnings EPS Surprises Significantly Despite Negative Results Anika Therapeutics Q1 2026 Earnings Massive EPS Beat Defies Expectations ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs EW Q1 2026 Earnings EPS Beat Drives Stock Higher Amid Limited Revenue Disclosure GXO Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains PLMR Q1 2026 Earnings Earnings Beat Driven by Underwriting Strength